Med. praxi. 2017;14(4):169-172 | DOI: 10.36290/med.2017.031

Thyroid glard disorders in pregnancy

MUDr. Nataša Kaňová
Oddělení klinické endokrinologie, Endokrinologický ústav, Praha

Physiological changes in pregnancy influence thyroid hormone levels which should be taken into consideration when assessingthe laboratory results of pregnant women. The most common disease of thyroid glands in pregnancy is autoimmune thyroiditis,which can cause hypothyroidism. Graves Basedow disease detrimentally affects the course of pregnancy and it´s essential tobe treated unlike transient hyperthyroidism, which disappears on its own without treatment. The diagnosis of the goiter andthyroid nodules during pregnancy has some specific difficulties and requires a particular attitude. Crucial to an optimal courseof pregnancy is the sufficient intake of iodine.

Keywords: humane chorionic gonadotropin (hCG), specific thyroxin binding globulin (TBG), hypothyroidism, fetal and neonatal
hyperthyroidism, screening for thyroid disease in pregnancy

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňová N. Thyroid glard disorders in pregnancy. Med. praxi. 2017;14(4):169-172. doi: 10.36290/med.2017.031.
Download citation

References

  1. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. The American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Alex Stagnaro-Green (Chair), Thyroid. 2011; 21: 10. Go to original source... Go to PubMed...
  2. Burman KD. Controversies Surrounding Pregnancy, Maternal Thyroid Status, and Fetal Outcome. Thyroid, 2009; 19(4): 323-326. Go to original source... Go to PubMed...
  3. Lazarus JH. Thyroid disorders associated with pregnancy. Treat. Endocrinol. 2005; 4(1): 31-41. Go to original source... Go to PubMed...
  4. Gartner R. Thyroid disorders during pregnancy. Dtsch Med Wochenschr. 2009; 134(3): 83-86. Go to original source... Go to PubMed...
  5. Haixia L, et al. Maternal subclinical hypothyroidism, thyroid autoimunity and the risk of miscarriage: a prospective cohort study. Thyroid. 2014; 24: 1642-1649. Go to original source... Go to PubMed...
  6. Matalon S, et al. Relationship of treated maternal hypothyroidism and perinatal outcome. J Reprod Med. 2006; 51(1): 59-63. Go to PubMed...
  7. Haddow JE, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549-555. Go to original source... Go to PubMed...
  8. Casey BM, et al. Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107: 337-341. Go to original source... Go to PubMed...
  9. Andersen SL, Olsen J, et al. Severity of Birth Defects after Propylthiouracil Exposure in Early Pregnancy. Thyroid 2014; 2.4: 1533-1540. Go to original source... Go to PubMed...
  10. Clementi M, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83: 43-46. Go to original source... Go to PubMed...
  11. Barbero P, et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 2008; 146A: 2390-2395. Go to original source... Go to PubMed...
  12. Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009: 132041. Go to original source...
  13. Ginsberg J. Diagnosis and Management of Grave's Disease. Can Med Assoc J. 2003; 168: 575-585.
  14. Azizi F. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 2003; 16: 1239-1243. Go to original source... Go to PubMed...
  15. Radetti G, et al. Foetal and Neonatal Thyroid Disorders. Minerva Pediatr. 2002; 54(5): 383-400. Go to PubMed...
  16. Doporučené postupy pro praktické lékaře [online]. Dostupné z: http://www.svl.cz/files/files/Doporucene-postupy-od-2013/Stitna-zlaza.pdf.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.